Gilead Sciences (GILD) Goodwill (2009 - 2026)

Gilead Sciences (GILD) has reported Goodwill for 18 consecutive years, with $8.3 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Goodwill changed 0.0% year-over-year to $8.3 billion; the trailing twelve-month figure through Jun 2026 stood at $8.3 billion (changed 0.0% YoY), and the FY2025 full-year result was $8.3 billion, changed 0.0% from the prior year.
• Goodwill steadied at $8.3 billion in Q2 2026 per GILD's latest filing, from $8.3 billion in the prior quarter.
• Across five years, Goodwill topped out at $8.3 billion in Q1 2022 and bottomed at $8.3 billion in Q1 2022.
• Historically, Goodwill has averaged $8.3 billion across 5 years, with a median of $8.3 billion in 2022.
• The sharpest annual moves came in 2022 and 2023: Goodwill slipped 0.24% in 2022, then changed 0.0% in 2023.
• Over 5 years, Goodwill stood at $8.3 billion in 2022, then changed by 0.0% to $8.3 billion in 2023, then changed by 0.0% to $8.3 billion in 2024, then changed by 0.0% to $8.3 billion in 2025, then changed by 0.0% to $8.3 billion in 2026.
• According to Business Quant data, Goodwill over the past three periods registered $8.3 billion, $8.3 billion, and $8.3 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.